Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).

Name: Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
License: Public Domain

Poitiers University Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

multiple myeloma, myeloma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 444885
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.